Electric light causes cancer?. Surely you're joking, Mr. Stevens

Mutation Research - Reviews in Mutation Research

Volumn 682, Issue 1, 2009, Pages 1-6

  Stevens, Richard G ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Breast cancer; Circadian disruption; Light at night

Indexed keywords

MELATONIN;

ANIMAL; BIOLOGY; BREAST CANCER; CANCER RISK; CARCINOGENESIS; CIRCADIAN RHYTHM; ELECTRICITY; ELECTROMAGNETIC FIELD; ENERGY; EVOLUTION; GENE FUNCTION; HAZARD; HUMAN; LIGHT; MOLECULAR GENETICS; NIGHT; NIGHT WORK; NONHUMAN; PHOTOTRANSDUCTION; PLANT; POWER SUPPLY; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SHIFT WORKER; SLEEP; THEORY;

ANIMALS; CHRONOBIOLOGY DISORDERS; CIRCADIAN RHYTHM; HUMANS; LIGHTING; MELATONIN; MODELS, BIOLOGICAL; NEOPLASMS; RISK FACTORS;

ANIMALIA; RODENTIA;

EID: 68749112696     PISSN: 13835742     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrrev.2009.01.003     Document Type: Review

References (74)

1. Dunning W.F., Curtis M.R., and Maun A.E. The effect of dietary fat and carbohydrate on diethylstilbestrol-induced mammary cancer in rats. Cancer Res. 9 (1949) 354-361
2. Braden L.M., and Carroll K.K. Dietary polyunsaturated fat in relation to mammary carcinogenesis in rats. Lipids 21 (1986) 285-288
3. Prentice R.L., Kakar F., Hursting S., Sheppard L., Klein R., and Kushi L.H. Aspects of the rationale for the Women's Health Trial. J. Natl. Cancer Inst. 80 (1988) 802-814
4. Holmes M.D., and Willett W.C. Does diet affect breast cancer risk?. Breast Cancer Res. 6 (2004) 170-178
5. Michels M.B., Mohllajee A.P., Roset-Bahmanyar E., Beehler G.P., and Moysich K.B. Diet and breast cancer: a review of the prospective observational studies. Cancer 109 12 Suppl. (2007) 2712-2749
6. Sieri S., Krogh V., Ferrari P., Berrino F., Pala V., Thiébaut A.C., et al. Dietary fat and breast cancer risk in the European prospective investigation into cancer and nutrition. Am. J. Clin. Nutr. 88 (2008) 1304-1312
7. Prentice R.L., Caan B., Chlebowski R.T., Patterson R., Kuller L.H., Ockene J.K., et al. Low-fat dietary pattern and risk of invasive breast cancer: the women's health initiative randomized controlled dietary modification trial. JAMA 295 (2006) 629-642
8. Wilson B.W., Anderson L.E., Hilton D.I., and Phillips R.D. Chronic exposure to 60-Hz electric fields: effects on pineal function in the rat. Bioelectromagnetics 2 (1981) 371-380
9. Cohen M., Lippman M., and Chabner B. Pineal gland and breast cancer. Lancet 2 (1978) 1381-1382
10. Pike M.C., Krailo M.D., Henderson B.E., Casagrande J.T., and Hoel D.G. 'Hormonal' risk factors, 'breast tissue age' and the age-incidence of breast cancer. Nature 303 (1983) 767-770
11. Jöchle W. Trends in photophysiologic concepts. Ann. N. Y. Acad. Sci. 117 (1964) 88-104
12. Khaetski I.K. Effect of hypothalamo-pituitary lesions induced by constant illumination on development of induced mammary tumors in rats. Vopr. Exp. Oncol. (Kiev) 1 (1965) 87-93
13. Anisimov V.N. The light-dark regimen and cancer development. Neuroendocrinol. Lett. 23 Suppl. 2 (2002) 28-36
14. Shah P.N., Mhatre M.C., and Kothari L.S. Effect of melatonin on mammary carcinogenesis in intact and pinealectomized rats in varying photoperiods. Cancer Res. 44 (1984) 3403-3407
15. Lewy A.J., Wehr T.A., Goodwin F.K., Newsome D.A., and Markey S.P. Light suppresses melatonin secretion in humans. Science 210 (1980) 1267-1269
16. W.A. Brown, Acknowledging Preindustrial Patterns of Sleep May Revolutionize Approach to Sleep Dysfunction, Appl. Neurol., May 26, 2006, available at: http://www.psychiatrictimes.com/display/article/10168/56881.
17. Fedrowitz M., and Löscher W. Exposure of Fischer 344 rats to a weak power frequency magnetic field facilitates mammary tumorigenesis in the DMBA model of breast cancer. Carcinogenesis 29 (2008) 186-193
18. Stevens R.G. Electric power use and breast cancer: a hypothesis. Am. J. Epidemiol. 125 (1987) 556-561
19. Schipper L., Ketoff A., Meyers S., and Hawk D. Residential electricity consumption in industrialized countries: changes since 1973. Energy 12 (1987) 1197-1208
20. Dong G., and Golden S.S. How a cyanobacterium tells time. Curr Opin Microbiol 11 (2008) 541-546
21. Berson D.M., Dunn F.A., and Takao M. Phototransduction by retinal ganglion cells that set the circadian clock. Science 295 (2002) 1070-1073
22. Provencio I., Jiang G., De Grip W.J., Hayes W.P., and Rollag M.D. Melanopsin: An opsin in melanophores, brain, and eye. Proc. Natl. Acad. Sci. U.S.A. 95 (1988) 340-345
23. Bunger M.K., Wilsbacher L.D., Moran S.M., Clendenin C., Radcliffe L.A., Hogenesch J.B., et al. Mop3 is an essential component of the master circadian pacemaker in mammals. Cell 103 (2000) 1009-1017
24. In: Rea M.S. (Ed). Lighting Handbook. 9th ed. (2000), Illuminating Engineering Society of North America, New York
25. Stevens R.G., Blask D.E., Brainard G.C., Hansen J., Lockley S.W., Provencio I., Rea M.S., and Reinlib L. Meeting report: the role of environmental lighting and circadian disruption in cancer and other diseases. Environ. Health Perspect. 115 (2007) 1357-1362
26. Schernhammer E.S., Kroenke C.H., Laden F., and Hankinson S.E. Night work and risk of breast cancer. Epidemiology 17 (2006) 108-111
27. Davis S., Mirick D.K., and Stevens R.G. Night shift work, light at night, and risk of breast cancer. J. Natl. Cancer Inst. 93 (2001) 1557-1562
28. Schernhammer E.S., Laden F., Speizer F.E., Willett W.C., Hunter D.J., Kawachi I., and Colditz G.A. Rotating night shifts and risk of breast cancer in women participating in the nurses' health study. J. Natl. Cancer Inst. 93 (2001) 1563-1568
29. Hansen J. Increased breast cancer risk among women who work predominantly at night. Epidemiology 12 (2001) 74-77
30. Hansen J. Editorial: Light at night, shiftwork, and breast cancer risk. J. Natl. Cancer Inst. 93 (2001) 1513-1515
31. Straif K., Baan R., Grosse Y., Secretan B.E., Ghissassi F.E., Bouvard V., et al. Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol. 8 (2007) 1065-1066
32. Hahn R.A. Profound bilateral blindness and the incidence of breast cancer. Epidemiology 2 (1991) 208-210
33. Stevens R.G. Epidemiological studies of light and breast cancer (abs). Neuroendocrinol. Lett. 23 suppl (2002) 94
34. Verkasalo P.K., Lillberg K., Stevens R.G., Hublin C., Partinen M., Koskenvuo M., and Kaprio J. Sleep duration and breast cancer: a prospective cohort study. Cancer Res. 65 (2005) 9595-9600
35. Pinheiro S.P., Schernhammer E.S., Tworoger S.S., and Michels K.B. A prospective study on habitual duration of sleep and incidence of breast cancer in a large cohort of women. Cancer Res. 66 (2006) 5521-5525
36. Wu A.H., Wang R., Koh W.P., Stanczyk F.Z., Lee H.P., and Yu M.C. Sleep duration, melatonin and breast cancer among Chinese women in Singapore. Carcinogenesis 29 (2008) 1244-1248
37. Kakizaki M., Kuriyama S., Sone T., Ohmori-Matsuda K., Hozawa A., Nakaya N., et al. Sleep duration and the risk of breast cancer: the Ohsaki Cohort Study. Br. J. Cancer 99 (2008) 1502-1505
38. Stevens R.G., and Rea M.S. Light in the built environment: potential role of circadian disruption in endocrine disruption and breast cancer. Cancer Causes Control 12 (2001) 279-287
39. Arnold A., and Papanikolaou A. Cyclin D1 in breast cancer pathogenesis. J. Clin. Oncol. 23 (2005) 4215-4224
40. Czeisler C.A., Shanahan T.L., Klerman E.B., Martens H., Brotman D.J., Emens J.S., et al. Suppression of melatonin secretion in some blind patients by exposure to bright light. N. Engl. J. Med. 332 (1995) 6-11
41. Foster R.G., Provencio I., Hudson D., Fiske S., De Grip W., and Menaker M. Circadian photoreception in the retinally degenerate mouse (rd/rd). J. Comp. Physiol. A 169 (1991) 39-50
42. Brainard G.C., Hanifin J.P., Greeson J.M., Byrne B., Glickman G., Gerner E., and Rollag M.D. Action spectrum for melatonin regulation in humans: evidence for a novel circadian photoreceptor. J. Neurosci. 21 (2001) 6405-6412
43. Lockley S.W., Brainard G.C., and Czeisler C.A. High sensitivity of the human circadian melatonin rhythm to resetting by short wavelength light. J. Clin. Endocrinol. Metab. 88 (2003) 4502-4505
44. Berson D.M. Phototransduction in ganglion-cell photoreceptors. Pflugers Arch. 454 (2007) 849-855
45. Hill S.M., and Blask D.E. Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture. Cancer Res. 48 (1988) 6121-6126
46. Blask D.E., Hill S.M., Orstead K.M., and Massa J.S. Inhibitory effects of the pineal hormone melatonin and underfeeding during the promotional phase of 7,12-dimethylbenzanthracene-(DMBA)-induced mammary tumorigenesis. J. Neural Transm. 67 (1986) 125-138
47. Dauchy D.T., Blask D.E., and Sauer L.A. Preparation of the inguinal fat pad for perfusion in situ in the rat: a surgical technique that preserves continuous blood flow. Contemp. Top. Lab. Anim. Sci. 39 (2000) 29-33
48. Blask D.E., Brainard G.C., Dauchy R.T., Hanifin J.P., Davidson L.K., Krause J.A., et al. Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats. Cancer Res. 65 (2005) 11174-11184
49. Charles D.R., and Luce-Clausen E.M. The kinetics of papilloma formation in benzpyrene-treated mice. Cancer Res. 2 (1942) 261-263
50. Berenblum I., and Shubik P. A new, quantitative, approach to the study of the stages of chemical carcinogenesis in the mouse skin. Br. J. Cancer 1 (1947) 383-391
51. Weinberg R.A. Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis. Cancer Res. 49 (1989) 3713-3721
52. Pitot H.C. Pathways of progression in hepatocarcinogenesis. Lancet 358 (2001) 859-860
53. Malling H.V. Reflections in Mutation Research: Incorporation of mammalian metabolism into mutagenicity testing. Mutation Res. 566 (2004) 183-189
54. Moolgavkar S.H., Day N.E., and Stevens R.G. Two-stage model for carcinogenesis: epidemiology of breast cancer in females. J. Natl. Cancer Inst. 65 (1980) 559-569
55. Kumle M. Declining breast cancer incidence and decreased HRT use. Lancet 372 (2008) 608-610
56. Stevens R.G., Beasley R.P., and Blumberg B.S. Iron-binding proteins and risk of canacer in Taiwan. J. Natl. Cancer Inst. 76 (1986) 605-610
57. Moolgavkar S.H., and Knudson A.G. Mutation and cancer: a model for human carcinogenesis. J. Natl. Cancer Inst. 66 (1981) 1037-1052
58. Trichopoulos D. Hypothesis: does breast cancer originate in utero?. Lancet 335 (1990) 939-940
59. Stevens R.G. Circadian disruption and breast cancer: from melatonin to clock genes. Epidemiology 16 (2005) 254-258
60. Anderson L.E., Morris J.E., Sasser L.B., and Stevens R.G. Effect of constant light on DMBA mammary tumorigenesis in rats. Cancer Lett. 148 (2000) 121-126
61. Storch K.F., Lipan O., Leykin I., Viswanathan N., Davis F.C., Wong W.H., and Weitz C.J. Extensive and divergent circadian gene expression in liver and heart. Nature 417 (2002) 78-83
62. Fu L., Pelicano H., Liu J., Huang P., and Lee C.C. The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 111 (2002) 41-50
63. Oklejewicz M., Destici E., Tamanini F., Hut R.A., Janssens R., and van der Horst G.T. Phase resetting of the mammalian circadian clock by DNA damage. Curr Biol. 18 (2008) 286-291
64. Gery S., Komatsu N., Baldjyan L., Yu A., Koo D., and Koeffler H.P. The circadian gene per1 plays an important role in cell growth and DNA damage control in human cancer cells. Mol. Cell 22 (2006) 375-382
65. Hua H., Wang Y., Wan C., Liu Y., Zhu B., Yang C., et al. Circadian gene mPer2 overexpression induces cancer cell apoptosis. Cancer Sci. 97 (2006) 589-596
66. Hunt T., and Sassone-Corsi P. Riding tandem: circadian clocks and the cell cycle. Cell 129 (2007) 461-464
67. Sahar S., and Sassone-Corsi P. Circadian clock and breast cancer: a molecular link. Cell Cycle 6 (2007) 1329-1331
68. Stevens R.G., Davis S., Thomas D.B., Anderson L.E., and Wilson B.W. Electric power, pineal function, and the risk of breast cancer. FASEB J. 6 (1992) 853-860
69. Bernstein L. The roles of physical activity and electric blankets in breast cancer. Epidemiology 12 (2001) 598-600
70. Schernhammer E.S., Rosner B., Willett W.C., Laden F., Colditz G.A., and Hankinson S.E. Epidemiology of urinary melatonin in women and its relation to other hormones and night work. Cancer Epidemiol. Biomark. Prev. 13 (2004) 936-943
71. Stevens R.G. Letter to editor. Epidemiology 13 (2002) 116
72. Stevens R.G. Letter to editor. Cancer Epidemiol. Biomark. Prev. 14 (2005) 551
73. Zhu Y., Brown H.N., Zhang Y., Stevens R.G., and Zheng T. Period3 structural variation: a circadian biomarker associated with breast cancer in young women. Cancer Epidemiol. Biomark. Prev. 14 (2005) 268-270
74. Kloog I., Haim A., Stevens R.G., Barchana M., and Portnov B.A. Light at night co-distributes with incident breast but not lung cancer in the female population of Israel. Chronobiol. Int. 25 (2008) 65-81